Rijksinstituut voor Volksgezondheid en Milieu
Differences in SARS-CoV-2 antibody prevalence at the end of the pre-vaccination period between age groups: A cross-sectional analysis of the multi-ethnic population-based HELIUS study | RIVM
Bron:
rivm.nl